Treatment with FTS (75 μM, 48 h, 5% serum) markedly increased the amounts of galectin-7 protein in the NF1-deficient MPNST cell lines ST88-14 (Figure 1A, 211% of control, p<0.001, n=6) and T265p21 (Supplementary Figure 1A). This evidence concerns the gene LGALS7 and malignant peripheral nerve sheath tumor.